We're working on profiling this company soon. Let us know you're interested by sending us a request here »
We're working hard to bring you this company's profile. Register here to get an alert as soon we're done.
In the meantime, if you are interested in participating in placements on this stock click "Follow" on the toolbar above.
ASX healthcare sector gains 1.99% in November while benchmark ASX 200 down 2.66% Mach7 rises 50% in...
Read ArticleASX gains 23 points or 0.27% in choppy session of trade Real estate plunges 2.11% while banks and r...
Read ArticleASX rises +0.5% before sliding back to just +0.18% Broad strength overall, however, with eight sect...
Read ArticleMorning, and welcome to Stockhead’s Top 10 (at 11… ish), highlighting the movers and shakers on the...
Read ArticleASX stumbles as announcement outage leaves traders scrambling to catch up Gold and oil climb, provi...
Read ArticleASX edges up just 10.8 points or 0.13% Gold holds steady with minor lift overnight as iron ore dips...
Read ArticleImugene takes the road to China with a new cell-therapy collab Heramed strikes its second US deal w...
Read ArticleASX struggles into the positive to add 0.14% Gold stocks, info tech lead gains Banks drag as BEN’s...
Read ArticleASX bounces back after Nvidia brings the goods, up 1.24% Materials and info tech lead gains, just e...
Read ArticleASX resists session lows of -0.53pc to close 0.02pc higher Info tech, energy, real estate lead gain...
Read ArticleASX burns through 118 points or 1.36% Energy only sector in green after crude oil gains Broad retre...
Read ArticleMorning, and welcome to Stockhead’s Top 10 (at 11… ish), highlighting the movers and shakers on the...
Read ArticleASX closes down 17 points or 0.19pc Banks, info tech weigh heavy Broad market gains with 130 of 200...
Read ArticleASX sheds 58 points or 0.66% to close at 8769 points Defensive sectors on the up while banks and in...
Read ArticleMorning, and welcome to Stockhead’s Top 10 (at 11… ish), highlighting the movers and shakers on the...
Read ArticleASX recovers from session lows of -0.91pc to fall -0.13pc Info tech, commodities weakness undercut...
Read ArticleASX healthcare sector fell 4.83% in October and is down more than 19% YTD CSL shares fall more than...
Read ArticleMorning, and welcome to Stockhead’s Top 10 (at 11… ish), highlighting the movers and shakers on the...
Read ArticleASX gains 0.41pc on broad sector strength Info tech, energy, finance power higher Rare earths, copp...
Read ArticleThe latest quarterlies show that key drug and diagnostics developers are well funded for the task C...
Read ArticleASX slides 13 points, down 0.15pc Energy gives up early gains, still positive as oil climbs 5pc Hea...
Read ArticleASX slides 0.71pc, down 64.7 points Broad sell down post-record close, 7 of 11 sectors lower Solid...
Read ArticleASX overcomes tepid morning to rise 36 points or 0.41pc Strong gains in blue chips, banks, real est...
Read ArticleASX closes 0.86% higher to reach a new 100-day high after hitting an intraday record Australia’s u...
Read ArticleASX 200 closes 0.19% higher after choppy session Strength in mining and energy stocks offset pullba...
Read ArticleAussie and Asian markets fall after Trump threatens more tariffs on China Gold and silver reach new...
Read ArticleCatapult Group is buying a German soccer analytics and talent scouting firm for $140 million PainCh...
Read ArticleASX lifts 22 points, back within striking distance of 9000-point mark Resources lead gains, with su...
Read ArticleASX flirts with record highs before sliding six points Strength in resources sector limits losses B...
Read ArticleAfter five months of consecutive gains, the ASX 200 fell 0.78% in September with nine of 11 sectors...
Read ArticleASX goes on the offence, up 1.13pc 8 of 11 sectors higher, led by healthcare and materials Strength...
Read ArticleMorning, and welcome to Stockhead’s Top 10 (at 11… ish), highlighting the movers and shakers on the...
Read ArticleASX crawls up just 0.17pc with 7 sectors lower Healthcare sharply lower as Trump threatens tariffs...
Read ArticleASX falls 0.83% tracking weaker US markets despite Fed rate cut Santos falls 12% after $30 billion...
Read ArticleAfter a strategy revamp, Noxopharm is targeting inflammatory diseases – lupus in particular Affecti...
Read ArticleASX slides 0.29pc with 6 sectors flashing red Healthcare, major banks major drivers of losses Recor...
Read ArticleMorning, and welcome to Stockhead’s Top 10 (at 11… ish), highlighting the movers and shakers on the...
Read ArticleThe S&P ASX 200 Health Care index fell 13.21% in August as a tough reporting season weighed on...
Read ArticleASX up 1pc on broad market gains Strong movement in big banks, lift almost 2pc Profit taking in gol...
Read ArticleASX plunges in worst performance since April All 11 sectors and every index lower Rising bond yield...
Read ArticleMorning, and welcome to Stockhead’s Top 10 (at 11… ish), highlighting the movers and shakers on the...
Read ArticleAustralia’s S&P/ASX 200 rose 3.10% in August and has posted gains of 12.33% so far for CY25 Mat...
Read ArticleASX ends flat after setting new intraday high Gold, small caps prop up market in face of bank losse...
Read ArticleASX bulls take a breath as market falls 0.7pc Healthcare leads losses, down 8.7pc Biotech heavyweig...
Read ArticleASX sets 17th intraday high for the year at 8963 Closes out trade at record 8959.3 points Broad sec...
Read ArticleMorning, and welcome to Stockhead’s Top 10 (at 11… ish), highlighting the movers and shakers on the...
Read ArticleASX rebounds to set new intraday high, up 0.53pc Origin Energy leads gains alongside utilities sect...
Read ArticleMorning, and welcome to Stockhead’s Top 10 (at 11… ish), highlighting the movers and shakers on the...
Read ArticleCommonwealth Bank shares fall 5pc on yearly results ASX falls from near all-time highs as sell down...
Read ArticleHighlights Market shows early softness after recent record closes Mining stocks advanc...
Read ArticleMorning, and welcome to Stockhead’s Top 10 (at 11… ish), highlighting the movers and shakers on the...
Read ArticleHighlights Early trade tone led by discretionary names and financials, with broader strengt...
Read ArticleAdvances on research and development tax incentives are proving a popular source of ancillary fina...
Read ArticleMorning, and welcome to Stockhead’s Top 10 (at 11… ish), highlighting the movers and shakers on the...
Read ArticleThe S&P ASX 200 Health Care index rose 9.05% in July with rotation into the sector gaining mome...
Read ArticleCopper prices crash 20pc Materials sector undercuts market, down 2.57pc Info tech rally not enough...
Read ArticleASX closes trade down 0.11pc Resources only sector on the up, adding 1.82pc Bitcoin smashes new all...
Read ArticleASX biotechs target global cell therapy market, projected to reach ~US$48bn by 2034 Arovella the on...
Read ArticleASX brushes aside RBA holding rates at 3.85% to close 0.02% higher Global markets feel jitters on U...
Read ArticleIt was a tale of two halves for the ASX today, and neither were great Caution abounds ahead of two...
Read ArticleMorning, and welcome to Stockhead’s Top 10 (at 11… ish), highlighting the movers and shakers on the...
Read ArticleThe ASX 200 Health Care Index fell 1.05% in June and remains the worst performing sector YTD down 6...
Read ArticleResources stocks surge; materials sector up 3.02pc ASX 200 Banks fall, shedding 1.3% as finance los...
Read ArticleEnergy sector powers higher again, up more than 5pc ASX uranium stocks surge ASX All Ords Gold inde...
Read ArticleMorning, and welcome to Stockhead’s Top 10 (at 11… ish), highlighting the movers and shakers on the...
Read ArticleDespite a strong start, the ASX has paired back gains to finish down 2.9 points or 0.03pc Weakness...
Read ArticleThe S&P/ASX 200 Health Care Index rose 1.59% in May but remains worst performing sector YTD dow...
Read ArticleAustralia’s S&P/ASX 200 rallied 4.20% in May along with global markets as US-tariff tensions ea...
Read ArticleASX climbs 0.3pc Gold stocks surge, up almost 2pc Retail sales soften, increasing chance of RBA rat...
Read ArticleASX falls as profit taking cuts banking stocks Energy sector booms on WDS project green light CPI c...
Read ArticleArovella is one of only a handful of biotechs pursuing CAR-iNKT immunotherapies – and is the only A...
Read ArticlePeter MacCallum Cancer Centre is Australia’s only public hospital dedicated to cancer care, researc...
Read ArticleASX jumped 0.5pc just before midday but pared back to just 0.03pc US-China trade negotiation announ...
Read ArticleHighlights asx 200 lifted in early trade following gains on the Nasdaq, with support from sect...
Read ArticleASX falls almost 1pc on Monday after setting new 20-day high last week Sectors in the red right acr...
Read ArticleThe S&P/ASX 200 Health Care Index rose 2.16% in April with the S&P/ASX 200 rallying 3.6% Mo...
Read ArticleASX has gained to cinch seventh straight session in the green 10 of 11 sectors on the up Bank index...
Read ArticleMorning, and welcome to Stockhead’s Top 10 (at 11… ish), highlighting the movers and shakers on the...
Read ArticleASX recovers from early dip to post 0.24pc gain Tech stocks surge with sector up 4pc Energy and Mat...
Read ArticleAdAlta (ASX:1AD) has announced aims to raise up to $1.3 million in a renounceable rights issue to ad...
Read ArticleEnergy and Tech sectors up about 1.5pc each Technology index boosted 1.26pc Materials the only lagg...
Read ArticleAdAlta subsidiary AdCella brings cutting-edge cellular immunotherapies from Asia – particularly Chi...
Read ArticleStockhead’s health and biotech expert Tim Boreham is back in the studio for another instalment of th...
Read ArticleAustralia’s S&P/ASX 200 records its first back-to-back monthly fall since October 2023, down 3....
Read ArticleASX rebounds 1pc with tech and real estate leading the way Nanosonics jumps after FDA gives approv...
Read ArticleAdAlta (ASX:1AD) has built on a deal with SYNthesis BioVentures Fund One, which plans to invest $500...
Read ArticleASX rises on global optimism and China boost Energy and miners shine, Mineral Resources jumps after...
Read ArticleHighlights Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease with limited treatm...
Read ArticleIdiopathic pulmonary fibrosis is a life-threatening lung disease AdAlta’s lead candidate AD-214 is...
Read ArticleASX dips as traders weigh China’s stimulus against Trump’s tariffs Miners soften blow but insurance...
Read ArticleThe S&P/ASX 200 Health Care Index fell 7.66% in February with the S&P/ASX 200 down 3.79% Mo...
Read ArticleStockhead’s Fraser Palamara chats withAdAlta (ASX:1AD) managing director Tim Oldham to get the short...
Read ArticleAdAlta prioritising East to West cellular immunotherapy strategy Company now has three products in...
Read ArticleAdAlta (ASX:1AD) has unveiled a new grand plan to take cell therapy candidates from Southeast Asia,...
Read ArticleTony Locantro has been a client advisor/investment manager in the stockbroking industry since 1998....
Read ArticleThe S&P/ASX 200 Health Care Index fell 1.85% in December but rose 7.51% overall in 2024 Mesobl...
Read ArticleASX 200 lifts on tech rally, miners struggle Barrick Gold threatens Mali shutdown over shipping res...
Read ArticleThe S&P/ASX 200 Health Care Index rose 2.89% in November as momentum returned to the sector Hea...
Read ArticleWhat is idiopathic pulmonary fibrosis (IPF)? What’s it like living with it? And what treatments are...
Read ArticleASX up as mining gains offset tech and bank losses Silex, Paladin and uranium stocks soar on supply...
Read ArticleASX healthcare stocks underperform but optimism grows Uscom, Respiri and Hitiq report mixed results...
Read ArticleAdAlta boosts leadership of subsidiaries with appointments of two consultant chief medical officers...
Read ArticleASX edges slightly up by 0.12pc as traders rethink rate cuts Consumer staples shine while gold min...
Read ArticleTony Locantro has been a client advisor/investment manager in the stockbroking industry since 1998....
Read ArticleStockhead’s Sarah Hughan sits down with AdAlta (ASX:1AD) CEO and managing director Tim Oldham to get...
Read ArticleStockhead’s Break it Down brings you today’s leading market news in under 90 seconds. In this episod...
Read ArticleAdAlta forms a clinical advisory board to advance its lead i-body enabled drug candidate AD-214 Boa...
Read ArticleASX 200 index falls despite gains in energy stocks Smaller oil and gas firms benefit from rising...
Read ArticleTo register for today's webinar click here. Platina Resources Limited (ASX:PGM) has confirmed two...
Read ArticleHealthcare stocks are doing relatively well globally in 2024 The sector could see more recovery as...
Read ArticleColes Group Ltd (ASX: COL) shares have enjoyed a strong run in 2024. They are up 18.7% this year to...
Read ArticleASX health stocks down in August and trail the broader market in 2024 CSL up 6,000pc since listing;...
Read ArticleThe ASX ended higher after a slow start Energy stocks leading while telcos and miners lagged Asian...
Read ArticleLocal markets opened lower this morning, with the decline slightly exceeding expectations. Despite a...
Read ArticleStockhead’s health and biotech expert Tim Boreham is back in the studio for another instalment of th...
Read ArticleTim Oldham – CEO & Managing Director – AdAlta Limited (ASX:1AD) is a clinical-stage biotechnol...
Read ArticleS&P/ASX 200 Health Care index up 5pc in July, 9.5pc YTD Health sector gains momentum with expec...
Read ArticleThe EMA has rejected the Alzheimer’s drug Leqembi, developed by Eisai and Biogen There is one ASX-l...
Read ArticleASX rises on Monday after Wall Street banked a belter on Friday All 11 local sectors higher, InfoT...
Read ArticleAdAlta entered collaboration with SYNthesis BioVentures Fund to establish AdCella during Q4 FY24 C...
Read ArticleThe ASX Health Care index saw a 4% increase in June Growth was driven by CSL and Cochlear Best biot...
Read ArticleS&P/ASX 200 Health Care closed flat in May 2024 brings challenges, but hopes are high for biot...
Read ArticleASX starts June positively, extending May gains Property prices in Australia rose by 0.8% in May,...
Read Article1AD raises $1.9 million of new equity from the exercise of listed 1ADOA options, led by an existing...
Read ArticleResearch shows Alzheimer’s is entirely preventable A poor diet and bad gut bacteria can increase th...
Read ArticleStockhead’s Sarah Hughan sits down with AdAlta (ASX:1AD) CEO and managing director Tim Oldham to get...
Read ArticleAdAlta (ASX:1AD) has announced an agreement under which Cell Therapies will be established...
Read ArticleASX flat on Monday, ahead of Federal Budget Tuesday night Oil weakness drags Energy sector lower C...
Read ArticleOptiscan signs deal with world-renowned Mayo Clinic AdAlta designates Cell Therapies as its manufac...
Read ArticleASX to open higher as the S&P 500 inches toward a new high Tesla to spend US$500m in in expa...
Read ArticleASX Health sector was in correction territory in April Why is the health sector different from othe...
Read ArticleThe ASX belts one out on Monday, up 0.8pc All 11 sectors are better for it Canterbury Resources gro...
Read ArticleAdAlta has received an institutional investment of up to $3m from New Life Sciences LLC and $700,00...
Read ArticleThere’s been a breakthrough in acne treatment Scientists have found a way to use skin bacteria to c...
Read ArticleStockhead’s Ashtyn Hiron sits down with AdAlta (ASX:1AD) CEO and managing director Tim Oldham to get...
Read ArticleSpecial Report: AdAlta and SYNthesis BioVentures Fund (SYNBV) are collaborating to form AdCella, a j...
Read ArticleIt’s been a tough couple of years for ASX health care with challenging economic conditions including...
Read ArticleTim Oldham – CEO & Managing Director – AdAlta (ASX:1AD) is a clinical-stage biotechnology comp...
Read ArticleASX health sector rises in line with broader markets in the past five days AdAlta reports positive...
Read ArticleAdAlta (ASX:1AD) has announced results from its Phase 1 extension study of lead asset AD-214...
Read ArticleASX Health Index down -1.5% for February 76 biotechs rose, and 78 fell during the month But essenti...
Read ArticleLocal markets end slightly higher IT Sector slumps 1.2pc Small Caps led by AT1 The ASX 200 trade...
Read ArticlePhase I extension study of AD-214 tested the target Phase II dose of AD-214 in healthy volunteers A...
Read ArticleTop-line results from a Phase I extension study of AdAlta’s (ASX: 1AD) lead asset AD-214 in the trea...
Read Article06 Mar 2024 - A snapshot of the stocks on the move, featuring Atomo Diagnostics (ASX:AT1), AdAlta (A...
Read ArticleTo register for Friday's webinar click here. Atomo Diagnostics (ASX:AT1) has announced securing pu...
Read ArticleAtomo jumps 90pc after reporting a significant sales order AdAlta up 20pc after revealing key resu...
Read ArticleStockhead’s Top 10 at 11, published each trading day, highlights the best (and worst) performing ASX...
Read ArticleViking Therapeutics doubled after results of weight loss drug trial Janux Therapeutics tripled on p...
Read ArticleASX200 dragged down by bad drugs The IT Sector is up 1.1pc, Healthcare is down about 3.2pc Small...
Read ArticleAdAlta AD-214 Phase I extension study results forecast for release at end of February Results cruci...
Read ArticleTim Oldham, CEO and Managing Director, AdAlta (ASX:1AD) is a clinical stage biotechnology company...
Read ArticleStockhead’s In-Case-You-Missed-It highlights today’s most interesting small cap stories that might h...
Read ArticleAdAlta’s AD-214 Phase 1 extension study interim data reinforce safety profile and dose selection Co...
Read ArticlePainChek’s European patent HeraMed signs deal with Telstra AdAlta announced interim Phase 1 results...
Read ArticleXi and Biden set to agree on restricting fentanyl Fentanyl is a synthetic opioid responsible for t...
Read ArticleASX200 closes +1.13% higher Property stocks, Industrials and IT Sector gain more than 2% Small caps...
Read ArticleAdAlta (ASX:1AD), a clinical-stage company developing novel protein and cell therapeutic pro...
Read ArticleNews relating to Novo Nordisk’s Ozempic has led to a selloff in some ASX stocks CSL, FPH, and RMD f...
Read ArticleL’Oréal to take minority stake in Chinese startup Shinehigh Innovation Shinehigh is developing supr...
Read ArticleStockhead’s In-Case-You-Missed-It highlights today’s most interesting small cap stories that might h...
Read ArticleAussie shares set to track Wall Street lower at the open CPI report will be the main focus this wee...
Read ArticleClinical stage drug discovery company AdAlta (ASX: 1AD) has completed the recruitment of healthy vol...
Read ArticleThe FDA has just approved an emergency use authorisation for new Covid-19 vaccines What is emergenc...
Read ArticleASX 200, Small Ords and Emerging Co’s indices all close -0.8% in the red Only the Energy Sector f...
Read ArticleEarnings reports dominated headlines in August Despite solid results from ASX healthcare giants, th...
Read ArticleAustralian biotech has attracted US investments in the last five years Among ASX stocks to get fund...
Read ArticleBiotech could be a US$4 trillion industry in 10 years Genetic engineering and weight loss are two g...
Read ArticleMesoblast plunged over 50pc after FDA response AdAlta progresses on Phase 1 extension study ResMed...
Read ArticleFutures predict the ASX will again open in the red as US earnings season continues on and US job dat...
Read ArticleLocal shares are poised to extend losses on Friday Tech titans Apple, Amazon and Atlassian reported...
Read ArticleThe end of pandemic and higher rates have subdued biotech market But there are signs now the sector...
Read ArticleThe ASX was higher by around 2.5% in July The best sectors were Tech and Energy We look at the best...
Read ArticleAdAlta (ASX:1AD) has released new data on the potential efficacy of AD-214 in humans with Id...
Read ArticleThe ASX has ended the final day of the trading week firmly in the red. All sectors were down with...
Read ArticleThe S&P ASX 200 closes 1.69% lower setting new 50-day low, with Emerging Companies index also f...
Read ArticleStockhead’s In-Case-You-Missed-It highlights some strongest performing ASX stocks that might have sl...
Read ArticleStockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) pe...
Read ArticleBiotech is making a comeback in 2023 There’s been a couple of breakthroughs on the ASX this year We...
Read ArticleOrphan diseases are those impacting less than 200,000 patients Orphan drug designation ensures an e...
Read ArticleStockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) pe...
Read ArticleArtificial intelligence is set to disrupt the healthcare sector AI could also help in drugs discove...
Read ArticleAmid the bombed-out biotech sector, early-stage developers of a new cancer immunotherapy have caught...
Read ArticleShareCafeWebinar Recap – KKO, VRX, 1AD & KNO Catch up on the full presentations from Kinetiko (...
Read ArticleShareCafeAdalta (ASX:1AD) – Webinar Presentation Tim Oldham – CEO and Managing Director – AdAlta is...
Read ArticleThe FDA declined regulate CBD-based supplements and food, citing safety reasons CBD products have g...
Read ArticleThe ASX 200 dropped 0.30% and the ASX XEC declined 0.20% Only 4 out of 11 sectors were higher, with...
Read ArticleAdAlta (1AD) welcomes two new investors associated via the Yuuwa Capital Venture Capital fund as sub...
Read ArticleJapanese startup OUI is on a mission to halve the world’s blindness with its smartphone-based devic...
Read ArticleMGC Pharma completes pre-clinical study on CimetrA Recce Pharma close to getting Aussie patent AdAl...
Read ArticleAdAlta (1AD) has been granted its second patent by the Japanese Patent Office for its lead program,...
Read ArticleThe ASX will open marginally lower on Tuesday Overnight, Wall Street was mixed but turned negative...
Read ArticleStockhead’s Top 10 at 10, published shortly after 10.30am each trading day, highlights the best (and...
Read ArticleASX health stocks have been out of favour this year with rotation away from growth to value sector...
Read ArticleHitIQ has entered into a two-year deal with the Premier League for its concussion management tech H...
Read ArticleWe take a look at how the 15 biotech IPOs that listed in 2021 are faring now Only two IPO stocks fr...
Read ArticleThe ASX will open lower on Thursday US and European sharemarkets are on a six-day losing streak Min...
Read ArticleBlood clot programs have taken the spotlight recently as new discoveries made Two ASX health stocks...
Read ArticleAs with almost every other drug developer on the planet, Vectus Biostsyems (ASX:VBS) co-founder Maur...
Read ArticleTwiggy’s Tattarang has seeded a new fund called Tenmile with $250m Tenmile will focus mainly on Aus...
Read ArticleUS FDA approves the first clinical trial using naturally derived psychedelic drugs It could open po...
Read ArticleA recent research reveals which biotech segments VCs are ploughing billions of dollars into We list...
Read ArticleAdAlta (1AD) receives a European patent from the European Patent Office for its lead product AD-124...
Read ArticleThe ASX 200 is set to open 4% lower today Wall Street crashes following higher than expected inflat...
Read ArticleThe Healthcare sector has been struggling as the pandemic wanes But most money managers are still b...
Read ArticleThe healthcare sector is experiencing a dry run IPO listings have fallen significantly on weak mark...
Read ArticleHighlights Today, the S&P/ASX 200 Financial sector (ASX:XFJ) traded approximately 0.843% low...
Read ArticleHighlights AdAlta’s lead i-body candidate AD-214 has bagged its first Indian patent. The patent...
Read ArticleAdAlta gets first patent in India RhinoMed to start selling Covid swaps and RAT kits in Canada AdA...
Read ArticleThe US Fed plans to reduce its bond back by US$95bn a month Nasdaq plunged another 2% ASX to open l...
Read ArticleBiotech sector has had a tough time recently But there are signs of things improving this year A lo...
Read ArticleThe ASX 200 Health Index (XHJ) is up by 0.30% at the time of writing, compared to the broader index...
Read ArticleTelehealth was already a growing space even before the pandemic, but COVID had launched it into the...
Read ArticleAdAlta (1AD) has been granted a patent for its lead product AD-214 by the China National Intellectu...
Read ArticleThe ASX 200 Health Index (XHJ) is trading lower by 0.27% at the time of writing, compared to the bro...
Read ArticleWall Street tumbles, ASX to fall as oil prices spike Aussie shares are set to follow Wall Street int...
Read ArticleThe ongoing lawsuit involving Johnson & Johnson (J&J)’s talc products took a controversial t...
Read ArticleShareCafeWebinar Recap – TNR, LBT, 1AD & LIT Catch up on the full webinar with presentation...
Read ArticleShareCafeAdAlta (ASX: 1AD) – Webinar Presentation Tim Oldham – CEO and Managing Director – AdAlta i...
Read ArticleAt the time of writing, the ASX XHJ Healthcare index is up 5.55% over the last five trading days, be...
Read ArticleIt’s been a rocky two weeks for small-cap health companies with 42 gaining ground, 76 losing it, and...
Read ArticleThe life sciences sector has emerged into the spotlight ever since the pandemic began. In the US, th...
Read ArticleThe ASX started the week lower as a result of a drop in the energy and financial sectors. Energy sha...
Read ArticleClinical-stage biotech company AdAlta (1AD) is looking to raise up to $5.95 million through a place...
Read ArticleThe so-called ‘Santa Claus Rally’ appears to be happening again this year with the ASX notching anot...
Read ArticleFor the first time in over a month, the ASX finished a week higher than where it began — even with t...
Read ArticleClinical-stage drug developer AdAlta (1AD) has entered a trading halt while it plans and completes...
Read ArticleThe ASX 200 Health Index (XHJ) is down by 0.20% at the time of writing, compared to the broader inde...
Read ArticleIt’s been a rocky two weeks for small-cap health companies, with 27 companies gaining ground, 89 los...
Read ArticleIt’s been a rocky two weeks for small-cap health companies, with 33 companies gaining ground, 86 los...
Read ArticleWall Street retreats overnight All three US stock market indexes retreated overnight, with the Dow J...
Read ArticleAdAlta (ASX:1AD) has announced an amendment to its funding agreement with MTPConnect under t...
Read ArticleAustralia’s bourse had its biggest decline since February 26 falling by over 2%. The ASX 200 fell 2....
Read ArticleAlthough earnings results were the main theme in August, there were also some notable healthcare bre...
Read ArticleThe CAR T-cell therapy (Chimeric Antigen Receptor) has been billed as a radical new way to cure canc...
Read ArticleHighlights: AdAlta and Carina Biotech enter a collaboration agreement to develop i-body enabled CAR...
Read ArticleIt was another positive close for the Australian bourse today with energy the standout sector. The A...
Read ArticleLeading the health stocks today is Nanosonics (ASX:NAN) up 19.69% after flagging FY21 revenues of $...
Read ArticleAdAlta Limited (ASX:1AD) and Carina Biotech have announced a collaboration agreement to deve...
Read ArticleIt’s been a mixed two weeks for small-cap health companies, with only 45 companies gaining ground, 7...
Read ArticleThe ASX 200 health stocks index is tracking the broader index well over the past two weeks. Both the...
Read ArticleWhisky manufacturer Lark Distilling Co (ASX:LRK) kept things warm during winter, leading a group of...
Read ArticleAustralian shares have extended gains for the second day in a row, rising by 0.91% despite more COVI...
Read ArticleIt’s been a mixed two weeks for small-cap health companies, with only 38 companies gaining ground, 7...
Read ArticleThe Aussie share market has fallen for two consecutive days, down by 0.46% today. Seven sectors were...
Read ArticleStockhead’s Top 10 at 10, published at 10.15am each trading day, highlights the best (and worst) per...
Read ArticleIt’s been a mixed two weeks for small-cap health companies, with 60 companies gaining ground and 52...
Read ArticleHere’s our fortnightly wrap of all the news driving ASX health stocks. The healthcare sector has ret...
Read ArticleShareCafeHidden Gems Webinar Recap OEL, 1AD, HRZ & LRS Catch up on the full webinar with presen...
Read ArticleShareCafeA new approach to drug discovery Presenter – Tim Oldham – CEO & Managing Director – Ad...
Read ArticleSummary The ASX 200 is trading lower by 8.60 points or 0.12% to 7,106.60 at the close, weighed d...
Read ArticleAdAlta (ASX:1AD) has announced that its commercial agreement with GE Healthcare is moving to...
Read ArticleSummary The ASX 200 trades higher by 15.20 points or 0.22% to 7045.50 at the close, led by gains...
Read ArticleSummary The ASX 200 is set to close the week with narrow gains, led by a strong rally in healthc...
Read ArticleSummary The ASX 200 gained 89.50 points or 1.29% to 7021.20 amid broad-based buying. Nine of th...
Read ArticleSummary The ASX 200 is heading towards its worst performance since late February, down 2% at 692...
Read ArticleSummary Island Pharmaceuticals and AdAlta have obtained patent protection for their lead program...
Read ArticleSummary Exopharm obtained firm commitments from institutional and sophisticated investors to rai...
Read ArticleHere’s our fortnightly wrap of all the news driving ASX health stocks. It’s been a mixed two weeks f...
Read ArticleSource: ShutterstockProfessional Summary Biotech penny stocks are extremely volatile, given the...
Read ArticleThe biopharmaceutical discovery and development company, Adalta Ltd [ASX:1AD] share price is higher...
Read ArticleThe AdAlta Ltd (ASX:1AD) share price is rocketing today following the positive news on its drug tri...
Read ArticleAdAlta (ASX:1AD) has soared to a one-and-a-half year high after its lead drug candidate — a molecule...
Read ArticleThe capital raising wave shows no sign of crashing with August’s total coming in at $4.7bn. Once aga...
Read ArticleA quick wrap of the ASX’s key winners and losers on Thursday, August 6. Data is taken after the mark...
Read ArticleA quick wrap of the ASX’s key winners and losers on Thursday, July 23. Data is taken after the marke...
Read ArticleA quick wrap of the ASX’s key winners and losers on Tuesday, July 7. Data is taken after the market...
Read ArticleAustralian biotechnology company AdAlta (ASX:1AD) says it has received Human Research Ethics...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleAt the turn of the millennium Megan Baldwin, high flying CEO of ophthalmology biotech Opthea (ASX:OP...
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read ArticleShark-based biotech Adalta (ASX:1AD) is one of 17 companies that have won federal government funding...
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read ArticleAustralian biopharmaceutical company AdAlta (ASX:1AD) has appointed a senior and experienced...
Read ArticleFirstWave Cloud Technology (ASX: FCT) has won technology super-aggregator Digital WholeSale Solution...
Read ArticleInvesting in Small-Cap Stocks Biotech is a dynamic and profitable sector for investors. Capital vent...
Read Article“History is bunk!’’ declared industrialist Henry Ford, but unfortunately for the oro-mucosal deliver...
Read ArticleMelbourne-based company AdAlta (ASX:1AD) has signed a commercial agreement for its i-body pl...
Read ArticleNo, its not photoshopped. This ratfish was caught in deep water in northern Norway. It’s no blue wha...
Read ArticleMedical tech stock AdAlta (ASX:1AD) thinks that when it comes to immunisation, what works for sharks...
Read ArticleBiotech company AdAlta (ASX: 1AD) signed taken a significant towards monetising its proprietary tech...
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read ArticleHere’s our fortnightly wrap of all the news driving ASX small cap health stocks. We last checked in...
Read ArticleStockhead’s Top 10 at 10 highlights the best (and the worst) performing ASX small caps in morning tr...
Read ArticleAs per the announcements on ASX, all the six stocks have released updates on changes in directors’ i...
Read ArticleAdAlta (ASX: 1AD), an Australian biotechnology company on its lead i-body therapeutic AD-214...
Read ArticleHealthcare Healthcare sector comprises of the companies that offer medical services, producing medi...
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read Article
Open an account with an online broker of your choice. If you do not have an existing broker, consider Vested Equities' A$9.50 flat fee platform.
Sign up now »Place your order however you wish. If you need advice on buying or selling, you should seek the assistance of a full service financial adviser experienced in small cap equities.
